Cover Image


Targetome - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 319996
出版日期 內容資訊 英文 20 Pages
Back to Top
TARGETOME:產品平台分析 Targetome - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 20 Pages



TARGETOME 為開發未滿足醫療需求的目標療法的生物科技企業,主要致力於胰臟癌和腫瘤轉移肝臟的治療藥開發。該公司提供生物標記的發現及檢驗,蛋白質體學及抗體的開發等服務。



  • 主要資訊
  • 企業資料


  • 主要的治療範圍


  • 各開發階段的開發中產品
  • 單劑產品


  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式


  • TGM-002
  • TGM-003
  • TGM-001
  • TGM-004
  • TGM-005


  • 各分子類型
  • ■TARGETOME:總公司和子公司的所在地



Product Code: GMDHC07764CDB


Global Markets Direct's, 'Targetome - Product Pipeline Review - 2015', provides an overview of the Targetome's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Targetome's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Targetome including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Targetome's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Targetome's pipeline products

Reasons to buy

  • Evaluate Targetome's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Targetome in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Targetome's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Targetome and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Targetome
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Targetome and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Targetome Snapshot
    • Targetome Overview
    • Key Information
    • Key Facts
  • Targetome - Research and Development Overview
    • Key Therapeutic Areas
  • Targetome - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Targetome - Pipeline Products Glance
    • Targetome - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Targetome - Drug Profiles
    • TGM-002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TGM-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TGM-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TGM-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TGM-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Targetome - Pipeline Analysis
  • Targetome - Pipeline Products by Molecule Type
  • Targetome - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Targetome, Key Information
  • Targetome, Key Facts
  • Targetome - Pipeline by Indication, 2015
  • Targetome - Pipeline by Stage of Development, 2015
  • Targetome - Monotherapy Products in Pipeline, 2015
  • Targetome - Preclinical, 2015
  • Targetome - Discovery, 2015
  • Targetome - Pipeline by Molecule Type, 2015

List of Figures

  • Targetome - Pipeline by Top 10 Indication, 2015
  • Targetome - Pipeline by Stage of Development, 2015
  • Targetome - Monotherapy Products in Pipeline, 2015
  • Targetome - Pipeline by Top 10 Molecule Type, 2015
Back to Top